BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8608530)

  • 41. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
    Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V
    Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.
    Ma H; Lu Y; Marchbanks PA; Folger SG; Strom BL; McDonald JA; Simon MS; Weiss LK; Malone KE; Burkman RT; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
    Breast Cancer Res; 2013; 15(5):R90. PubMed ID: 24070170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An admixture scan in 1,484 African American women with breast cancer.
    Fejerman L; Haiman CA; Reich D; Tandon A; Deo RC; John EM; Ingles SA; Ambrosone CB; Bovbjerg DH; Jandorf LH; Davis W; Ciupak G; Whittemore AS; Press MF; Ursin G; Bernstein L; Huntsman S; Henderson BE; Ziv E; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3110-7. PubMed ID: 19843668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
    Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
    J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in estrogen receptor subtype according to family history of breast cancer among Hispanic, but not non-Hispanic White women.
    Hines LM; Risendal B; Slattery ML; Baumgartner KB; Giuliano AR; Byers T
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2700-6. PubMed ID: 18843012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women.
    Wenten M; Gilliland FD; Baumgartner K; Samet JM
    Ann Epidemiol; 2002 Aug; 12(6):435-4. PubMed ID: 12160603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study.
    Setiawan VW; Monroe KR; Wilkens LR; Kolonel LN; Pike MC; Henderson BE
    Am J Epidemiol; 2009 May; 169(10):1251-9. PubMed ID: 19318616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.
    Anderson WF; Chu KC; Chatterjee N; Brawley O; Brinton LA
    J Clin Oncol; 2001 Jan; 19(1):18-27. PubMed ID: 11134191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triple-negative breast cancers are increased in black women regardless of age or body mass index.
    Stead LA; Lash TL; Sobieraj JE; Chi DD; Westrup JL; Charlot M; Blanchard RA; Lee JC; King TC; Rosenberg CL
    Breast Cancer Res; 2009; 11(2):R18. PubMed ID: 19320967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.
    Ruder AM; Lubin F; Wax Y; Geier A; Alfundary E; Chetrit A
    Cancer; 1989 Jul; 64(1):196-202. PubMed ID: 2731116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Second primary breast cancer occurrence according to hormone receptor status.
    Kurian AW; McClure LA; John EM; Horn-Ross PL; Ford JM; Clarke CA
    J Natl Cancer Inst; 2009 Aug; 101(15):1058-65. PubMed ID: 19590058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The epidemiology of triple-negative breast cancer, including race.
    Trivers KF; Lund MJ; Porter PL; Liff JM; Flagg EW; Coates RJ; Eley JW
    Cancer Causes Control; 2009 Sep; 20(7):1071-82. PubMed ID: 19343511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disparities in breast cancer characteristics and outcomes by race/ethnicity.
    Ooi SL; Martinez ME; Li CI
    Breast Cancer Res Treat; 2011 Jun; 127(3):729-38. PubMed ID: 21076864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Racial Differences in Utilization of Breast Conservation Surgery: Results from the National Cancer Data Base (NCDB).
    Thomas P; Killelea BK; Horowitz N; Chagpar AB; Lannin DR
    Ann Surg Oncol; 2016 Oct; 23(10):3272-83. PubMed ID: 27503494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase.
    Hou N; Huo D
    Breast Cancer Res Treat; 2013 Apr; 138(2):633-41. PubMed ID: 23446808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Racial/ethnic disparities in knowledge about one's breast cancer characteristics.
    Freedman RA; Kouri EM; West DW; Keating NL
    Cancer; 2015 Mar; 121(5):724-32. PubMed ID: 25624186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
    Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
    Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.